(Q53595739)

16 May 2018

title

The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis. (English)

1 reference

16 May 2018

author

Oleg N. Demidov

1

1 reference

16 May 2018

Albert J Fornace

5

1 reference

16 May 2018

author name string

C Kek

2

1 reference

16 May 2018

S Shreeram

3

1 reference

16 May 2018

O Timofeev

4

1 reference

16 May 2018

E Appella

6

1 reference

16 May 2018

D V Bulavin

7

1 reference

16 May 2018

language of work or name

English

0 references

publication date

2 October 2006

1 reference

16 May 2018

published in

Oncogene

1 reference

16 May 2018

volume

26

1 reference

16 May 2018

issue

17

1 reference

16 May 2018

page(s)

2502-2506

1 reference

16 May 2018

Chemical inhibition of Wip1 phosphatase contributes to suppression of tumorigenesis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

Mechanism of p38 MAP kinase activation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

The 17q23 amplicon and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

A subtle change in p38 MAPK activity is sufficient to suppress in vivo tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

Substrate specificity of the human protein phosphatase 2Cdelta, Wip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210032

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210032

1 reference

16 May 2018

1 reference

16 May 2018